{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:46:50Z","timestamp":1789246010263,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Stavanger University Hospital"},{"name":"Norwegian Chapter, International League Against Epilepsy"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.seizure.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T02:00:56Z","timestamp":1340762456000},"page":"573-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comorbid and underlying diseases\u2014Major determinants of excess mortality in epilepsy"],"prefix":"10.1016","volume":"21","author":[{"given":"Dag","family":"Aurlien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Petter","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Gjerstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Taub\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2012.05.015_bib0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1528-1157.2000.tb00124.x","article-title":"Mortality risk in an adult cohort with a newly diagnosed unprovoked epileptic seizure: a population-based study","volume":"41","author":"Lindsten","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/brain\/awq378","article-title":"The long-term risk of premature mortality in people with epilepsy","volume":"134","author":"Neligan","year":"2011","journal-title":"Brain"},{"issue":"Suppl 11","key":"10.1016\/j.seizure.2012.05.015_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1167.2005.00403.x","article-title":"Mortality of epilepsy in developed countries: a review","volume":"46","author":"Forsgren","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0020","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1111\/j.1528-1167.2010.02711.x","article-title":"Temporal trends in the mortality of people with epilepsy: a review","volume":"51","author":"Neligan","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 11","key":"10.1016\/j.seizure.2012.05.015_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1528-1167.2005.00411.x","article-title":"Sudden unexpected death in epilepsy: a review of incidence and risk factors","volume":"46","author":"Tomson","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0030","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1997.tb01194.x","article-title":"Cause-specific mortality in epilepsy: a cohort study of more than 9000 patients once hospitalized for epilepsy","volume":"38","author":"Nilsson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1528-1167.2011.03334.x","article-title":"Increased risk of sudden unexpected death in epilepsy (SUDEP) in females using lamotrigine: a nested, case control study","volume":"53","author":"Aurlien","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(08)70202-3","article-title":"Sudden unexpected death in epilepsy: current knowledge and future directions","volume":"7","author":"Tomson","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2012.05.015_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1528-1157.1974.tb04941.x","article-title":"Epilepsy and mortality rate and causes of death","volume":"15","author":"Zielinski","year":"1974","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1528-1157.1980.tb04088.x","article-title":"Mortality in patients with epilepsy","volume":"21","author":"Hauser","year":"1980","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1528-1157.1984.tb03480.x","article-title":"Heart disease mortality and morbidity in patients with epilepsy","volume":"25","author":"Annegers","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0140-6736(94)92270-5","article-title":"Mortality from epilepsy: results from a prospective population based study","volume":"344","author":"Cockerell","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2012.05.015_bib0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(79)91505-8","article-title":"Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy","volume":"314","author":"White","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2012.05.015_bib0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jnnp.56.2.149","article-title":"Mortality in patients with epilepsy: a study of patients in long term residential care","volume":"56","author":"Klenerman","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2012.05.015_bib0075","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1528-1167.2005.00344.x","article-title":"Somatic comorbidity of epilepsy in the general population in Canada","volume":"46","author":"T\u00e9llez-Zenteno","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(04)15946-1","article-title":"Late-onset seizures as a predictor of subsequent stroke","volume":"363","author":"Cleary","year":"2004","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.seizure.2012.05.015_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","author":"Svalheim","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2012.05.015_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1528-1157.1998.tb01381.x","article-title":"Do males 30\u201350 years of age with chronic epilepsy and on long-term anticonculsant medication have lower-than-expected risk of developing coronary heart disease?","volume":"39","author":"Nakken","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","article-title":"The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.05.015_bib0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/DHPS.S13070","article-title":"Suicidal behaviour and antiepileptic drugs in epilepsy: analysis of the emerging evidence","volume":"3","author":"Mula","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.seizure.2012.05.015_bib0110","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/j.1528-1167.2009.02133.x","article-title":"Underlying cause of death in incident unprovoked seizures in the urban community of Northern Manhattan, New York City","volume":"50","author":"Benn","year":"2009","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131112001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131112001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:41:04Z","timestamp":1761010864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131112001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1059131112001458"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2012.05.015","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbid and underlying diseases\u2014Major determinants of excess mortality in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2012.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}